ABOUT PRODUCTS PIPELINE INVESTORS CAREERS PARTNERSHIPS EXPANDED ACCESS COMPANY PROFILE CORPORATE OFFICERS BOARD OF DIRECTORS CORPORATE GOVERNANCE Vanda is a leading global biopharmaceutical company. Vanda is developing important new medicines to improve the lives of patients. We use new technologies, including genetics and genomics, to inform our drug discovery, our clinical trials, and our commercial positioning of our compounds. We are working to advance the use of novel approaches to deliver these new medicines to patients. Our CEO, Mihael Polymeropoulos, MD, founded Vanda in 2003 in partnership with Care Capital LLC, a prominent biopharmaceuticals-focused investment firm, and Bio*One Capital, an investment arm of the Singapore government with a focus on new biomedical enterprises. CORPORATE OFFICERS Working together for a common goal. Mihael H. Polymeropoulos, MD President, Chief Executive Officer and Chairman of the Board Gunther Birznieks Senior Vice President, Business Development Tim Williams Senior Vice President, General Counsel and Secretary Deepak Phadke, PhD Vice President of Manufacturing Kevin Moran Senior Vice President, Chief Financial Officer and Treasurer Joakim Wijkstrom Senior Vice President, Chief Marketing Officer Scott Howell Chief People Officer BOARD OF DIRECTORS Knowledge. Experience. Commitment. Mihael H. Polymeropoulos, MD President, Chief Executive Officer and Chairman of the Board H. Thomas Watkins Lead Independent Director Stephen Ray Mitchell Director Richard W. Dugan Director Phaedra Chrousos Director Anne Sempowski Ward Director BOARD OF DIRECTORS Corporate Governance Audit Committee Richard W. Dugan (Financial Expert) Chair, Member Anne Sempowski Ward Member Phaedra Chrousos Member Compensation Committee H. Thomas Watkins Chair, Member Richard W. Dugan Member Anne Sempowski Ward Member Nominating / Corporate Governance Committee H. Thomas Watkins Chair, Member Phaedra Chrousos Member Stephen Ray Mitchell Member Guidelines Vanda Pharmaceuticals Inc. Corporate Governance Guidelines PDF 27.0 KB Vanda Germany - 2020 Payments to Patient Organizations PDF 285.0 KB Vanda Hotline Committee Charters Audit Committee PDF 46.0 KB Compensation Committee PDF 33.0 KB Nominating and Corporate Governance Committee PDF 17.0 KB Governance Documents Whistleblower Policy PDF 100.0 KB Code of Business Conduct and Ethics PDF 118.0 KB Securities Trading PDF 125.0 KB Reg FD Policy PDF 64.0 KB Amended and Restated Bylaws PDF 138.0 KB Amended and Restated Certificate of Incorporation PDF 86.0 KB Certificate of Designation PDF 164.0 KB Comprehensive Compliance Program PDF 17.0 KB Annual CA Declaration of Compliance PDF 135.0 KB ABOUT Company Profile Corporate Officers Board of Directors Corporate Governance PRODUCTS HETLIOZ® Fanapt® PIPELINE Clinical Development Pipeline INVESTORS Stock Information News Presentations Financial Information Corporate Governance Analyst Coverage Contact Us CAREERS Career Search TERMS & CONDITIONS PRIVACY NOTICE COPYRIGHT © 2021 VANDA PHARMACEUTICALS